Literature DB >> 6854125

Degradation of human 125I-interferon alpha by isolated perfused rabbit kidney and liver.

V Bocci, K E Mogensen, M Muscettola, A Pacini, L Paulesu, G P Pessina, S Skiftas.   

Abstract

Rabbit livers and kidneys were isolated and perfused with homologous blood. After equilibration, human IFN alpha labeled with 125I and an excess of cold IFN alpha were added, and blood samples were withdrawn at predetermined times. Protein-bound and acid-soluble radioactivity together with biological (antiviral) activity were measured. Our results show that although liver exerts a minimal catabolism, the kidney filters and breaks down a considerable amount of IFN alpha. The parallelism between protein-bound radioactivity and biological activity decay curves indicates that IFN carefully labeled with 125I can be reliably used for metabolic investigations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854125

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

1.  Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice.

Authors:  D S Wang; S Ohdo; S Koyanagi; H Takane; H Aramaki; E Yukawa; S Higuchi
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.

Authors:  V Bocci; M Muscettola; G Grasso; Z Magyar; A Naldini; G Szabo
Journal:  Experientia       Date:  1986-04-15

4.  Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap.

Authors:  Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

5.  Receptor mediated pathways for interferon action: in vivo implications.

Authors:  K E Mogensen; M T Bandu; F Vignaux; G Uze; P Eid
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  Receptor dynamics of closely related ligands: "fast' and "slow' interferons.

Authors:  G Uzé; K E Mogensen; M Aguet
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.